Healthcare
Live Price
Offline$26.53
+0.00% today
1Y Change
+5.28%
Window
Jun 26, 2025 โ Jun 18, 2026
Coverage: 246 bars ยท Jun 26, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Fagron N.V. (ARSUF) is a Healthcare stock with a market cap of $1.80B. The stock last traded around $26.53 and up 5.3% across the available one-year price window (Jun 26, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +9.2%, EPS growth of +12.7%, a dividend yield of 1.4%. What stands out right now is revenue +9.2%, EPS +12.7%, free cash flow +63.5% with operating margin 15.5% and ROIC 11.1%. The dividend is present but secondary, with a yield around 1.4%. Valuation is more restrained than many high-expectation growth names at P/E 19.7 and price/sales 1.9. Stock Foundry combines ARSUF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+9.2% vs +7.6% peer median
Operating Margin
Below sector median
+15.5% vs +19.4% peer median
P/E
Below sector median
19.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Feb 12, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +9.2% and EPS at +12.7%, with operating margin around 15.5%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 30, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.3% over the next 5 trading days and finished higher after 1 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Feb 12, 2026 | โ | +1.9% | +3.8% | +3.8% |
2025 Jul 31, 2025 | โ | +0.0% | +0.0% | +0.0% |
2025 Feb 20, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ARSUF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ARSUF Max Drawdown
-6.75%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for ARSUF and SPY.
Company Overview
Fagron N.V.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.